icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
Prevalence and Impact of Baseline Resistance-Associated Variants (RAVs) on the Efficacy of Ledipasvir/Sofosbuvir or Simeprevir/Sofosbuvir Against GT1 HCV Infection: HCV-TARGET Interim Analysis
 
 
  Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Gary P. Wang, Jackie Reeves, Norah Terrault, Joseph Lim, Giuseppe Morelli, Alexander Kuo, Josh Levitsky, Kenneth Sherman, Lynn M. Frazier, Ananthakrishnan Ramani, Joy Peter, Lucy Akuskevich, Michael W. Fried, David R. Nelson
University of Florida, North Florida/South Georgia Veterans Health System, Monogram Biosciences, University of California, San Francisco, Yale University School of Medicine, University of California, San Diego, Northwestern University Feinberg School of Medicine, University of Cincinnati, Liver Wellness Center, Mountainview Medical Center, University of North Carolina

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7

EASL8

EASL9

EASL10

EASL11

EASL12